DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

Similar documents
LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Emulsions. Purpose of emulsions and of emulsification:

DEVELOPMENT AND EVALUATION OF ORAL RECONSTITUTABLE SYSTEMS OF CEPHALEXIN

A REVIEW ON DRY SYRUPS FOR PAEDIATRICS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LIQUID PREPARATIONS FOR ORAL USE

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

TABLET DESIGN AND FORMULATION

Contents. Introduction

REVISION OF MONOGRAPH ON TABLETS. Tablets

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Formulation and Evaluation

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

VIVAPUR MCG. Microcrystalline Cellulose (MCC) and Carboxymethylcellulose Sodium (Na-CMC), NF, Ph.Eur., E460(i)&E466. Dispersible Cellulose

Agenda Item 7e CX/FAC 01/9 February 2001 JOINT FAO/WHO FOOD STANDARDS PROGRAMME

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

02/09/2016. Roles of Excipients in Pharmaceuticals:

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

SCIENTIFIC DISCUSSION

Granulation Aggregation

Easy, fast and reliable!

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

US A United States Patent (19) 11 Patent Number: 5,635,209 Groenewoud et al. 45 Date of Patent: Jun. 3, 1997

Easy, fast and reliable!

A novel, sugar-free binder syrup for healthier snacks

FROZEN DRINKS DATA Marylou's News, Inc.

Liquid Crystal System for Manufacture of Personal Care Cleansing Products

UNISHAPES MACROSCOPIC PELLETS OF DIFFERENT FORMS AND COLORS FOR COSMETIC PRODUCTS

FLAVOUR FLOW & ADHESION

Gellan Gum. Rm.1702, West Unit, No. 41, Donghai Xi Rd, Qingdao, China Post Code:

Industrial Pharmacy (3) Solutions as a dosage form. DR.Saad.M.YACOUB

SCIENTIFIC DISCUSSION

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

LAB.2. Tablet Production Methods

Mixed solvent systems;; spirits, and elixirs

PARENTERAL PREPARATIONS

KING KHALID UNIVERSITY

IMPRESSION MATERIALS

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

SCIENTIFIC DISCUSSION

Pharmaceutics I. Unit 7 EMULSIONS

what is Fibersol-2 AG?

Application Note No. 256/2017

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

What is shelf life extension?

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

15. Mixed fertilizers sources preparations- their compatibility advantages

Nutrition Facts. Cake and Danish Nutrition and Ingredient Information. Angel Food Cake

(12) United States Patent

SCIENTIFIC DISCUSSION

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

FLORITER. New Technology for Innovative Formulation Design.

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Water-free Anionic Surfactants

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

B. semisolid materials consisting of hydrophilic and hydrophobic portions

Mylan Laboratories Limited F-4 & F-12, Malegaon MIDC, Sinnar Nashik Maharashtra State, India

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

SCIENTIFIC DISCUSSION. Efavirenz

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

Bakery - Talerico-Martin

Contract Manufacturing Fluid Bed Technology. Drying. Spray granulation. Coating. Agglomeration. Instantization.

Secundum Artem. Stability of Extemporaneously Prepared Oral Liquid Formulations - Part VII

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

METOLOSE: CONTENTS PAGE

Folic Acid in Human Nutrition

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

SCIENTIFIC DISCUSSION. Antimycobacterial (J04AC01).

Stability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date

REFERENCES OVERVIEW ADVANTAGES AEROSOLS. Aerosols. and Foams

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

Defoaming Surfactants

Texturizing Solutions: Serving customers across categories

Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs

Parenteral products-definition

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Development of Nutrient Delivery Systems: Ingredients & Challenges

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

CODEX STANDARD FOR COCOA POWDERS (COCOAS) AND DRY MIXTURES OF COCOA AND SUGARS CODEX STAN

TABLET COATING 2. Lec. 9

DRAFT PROPOSAL FOR REVISION OF GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS. (July 2012) Draft for comment

Designing a Non-Soap Cleansing Bar

SCIENTIFIC DISCUSSION

UNIT 2 SOLID AND LIQUID DOSAGE FORMS

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

SCIENTIFIC DISCUSSION

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

Transcription:

DRY SYRUPS SEMINAR BY SWAPNA.M M.PHARMACY Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL

CONTENTS DEFINITION CHARACTERISTICS OF SUSPENSIONS FOR RECONSTITUTION COMMONLY USED INGREDIENTS PREPARATION OF DRY MIXTURE STABILITY CONSIDERATIONS GUIDELINES FOR STABILITY TESTING CONCLUSION REFERENCES

Dry Syrups Definition Dry powders for oral suspension are powder mixtures that require the addition of water (reconstitution) at the time of dispensing and are mostly for paediatric use. These are called dry syrups or reconstitutable oral suspensions. Rationale Inadequate chemical stability of the drug in the aqueous vehicle. Avoid the physical stability problems like viscosity changes, conversion of polymorphic form, incompatibility, crystal growth, caking.

Reduces the weight of final product because the aqueous vehicle is absent Shipped without regard to seasonal temperatures

Required characteristics of Suspensions for reconstitution Powder blend must be a uniform mixture of the appropriate concentration of each ingredient. During reconstitution the powder blend must disperse quickly and completely in the aqueous vehicle. Reconstituted suspension must be easily redispersed and poured by the patient to provide accurate and uniform dose. Final product must have an acceptable appearance, odor, and taste.

Commonly used Ingredients Frequent Suspending agent Wetting agent Sweetener Preservative Flavor Buffer Color Infrequent Anticaking Agent Flocculating agent Solid diluent Antifoaming agent Granule binder Granule disintegrant Antioxidant Lubricant Number of ingredients should be kept minimum. An ingredient that performs more than one function Sucrose All ingredients should disperse rapidly on reconstitution.

Typical Reconstitutable Oral Suspensions Drug Amoxicillin trihydrate Ampicillin Cephalexin Dicloxacillin sodium Erythromycin ethylsuccinate Pencillin V potassium Ampicillin and Probenecid Manufacturers SmithKline Beecham Biocraft Dista Apothecan Abbott Lilly Biocraft Nearly all drugs formulated as reconstitutable oral suspensions are antibiotics Sodium dicloxacillin is water soluble, it is formulated as an insoluble form in suspension to help mask the odor and taste

Suspending agents suitable for use in Suspensions for Reconstitution Acacia Carboxy methylcellulose sodium Iota carrageenan Microcrystalline cellulose with sodium CMC Povidone Propylene glycol alginate Silicon dioxide, colloidal Tragacanth Xanthan gum Suspending agents should be easily dispersed by vigorous hand shaking during reconstitution. Combination of microcrystalline cellulose and sodium CMC is a common suspending agent.

Natural gums Anionic and include exudates of tree and extracts from seaweed e.g. Carrageenan and alginates. Alginates produce highly viscous solutions and the iota carrageenans produce thixotropic dispersions. Acacia and tragacanth have been used as suspending agents for many years. Disadvantage: Variation in color, viscosity, gel strength and hydration rate. Xanthan gum Common suspending agent in suspensions for reconstitution. Produced by microbial fermentation, good batch-to-batch uniformity and few microbial problems. Required concentrations for rapid dispersion during reconstitution must be determined for each suspending agent.

Sweeteners Sweeteners can mask the unfavorable taste and enhance patient acceptance in the pediatric population that uses this product. Any increased viscosity as a result of the sweetener aids suspension of the drug particles. Sucrose can perform both above functions of sweetener and suspending agent, and serve as a diluent in the dry mixture. Others include Mannitol, Dextrose, Aspartame, Sodium saccharin

Wetting Agents Drugs in suspension are hydrophobic, repel water and are not easily wetted. Surfactants are commonly used to aid in the dispersion of hydrophobic drugs. Excess wetting agent can produce foaming and impart an unpleasant taste. Polysorbate 80 is a common wetting agent. Nonionic and is chemically compatible with both cationic and anionic excipients and drugs. Used in concenrations < 0.1 %. Another common wetting agent is sodium lauryl sulfate. Anionic and may be incompatible with cationic drugs.

Other ingredients Buffers, Preservatives, Flavors & Colors Buffers are used to maintain the optimum ph for all ingredients. - Sodium citrate buffer. Preservatives are required in most suspensions because the suspending agents and sweetener are often good growth media for microorganisms. - Sucrose in sufficent concentrations (60% w/w) - Sodium benzoate Natural and Artificial flavors Raspberry, Pineapple FD&C Red No 40 and Yellow No 6. Common problem in dry mixtures is poor powder flow and caking - Anticaking agents, Amorphous silica gel

Preparation of Dry Mixture Powder Blends Granulated Products Combination Products

Powder Blends Mixing the ingredients of the dry mixture in powder form. Ingredients present in small quantities may require a two stage mixing operation. Mixer should rapidly and reliably produce a homogeneous mixture. Advantages Least capital equipment and energy Least likely to have chemical and stability problems because no heat or solvents are used. Low moisture content can be achieved in dry mixture. Disadvantages Prone to homogeneity problems Particle size and Powder flow Loss of the active ingredient during mixing Potent drug used in very low concentrations

Granulated Products Wet granulation is the usual process and granulating fluid is water or an aqueous/nonaqueous binder solution. Drug can be dry blended with other ingredients or it can be dissolved or suspended in the granulating fluid. Solid ingredients are blended and massed with granulating fluid in a planetary mixer. Wet mass is formed into granules : Vibratory sieve, Oscillating granulator or mill Granules dried in a tray oven or Fluid bed drier. Dried granules screened in a vibratory seive or oscillating granulator to break up or remove aggregates or granules.

Granulated Products Advantages Improved appearance Improved flow characteristics Less segregation problems Less generation of dust during filling operations Disadvantages More capital equipment and energy Difficult to remove the last traces of granulating fluid, reduce the stability Uniform granulation is necessary, excess of very small particles, or fines, will result in rapid segregation.

Combination Product Less energy and equipment for granulation may be required if majority of the diluent can be added after granulation. Heat sensitive ingredients, such as flavors can be added after drying of granules. First to granulate some of the ingredients and blend the remaining ingredients with the dried granules before filling into container. Disadvantages Risk of nonuniformity Particle sizes of various fractions should be carefully controlled.

Advantages and Disadvantages of types of Dry mixtures Type Advantage Disadvantage Powder blend Economy Low incidence of instability Mixing&Segregation problems Losses of drugs Granulated Products Appearance Flow characteristics Less segregation Less dust Cost; Effects of heat & granulating fluid on drug and excipients Combination product Reduced cost Use of heat sensitive ingredients Ensuring nonsegregating mix of granular and nongranular ingredients

Processing the Dry Mixture Recommended Guidelines for processing the Dry mixture Use efficient mixing. Determine an adequate duration of mixing time. Avoid accumulation of heat and moisture during mixing. Limit temperature/humidity variations (70 C at 40% RH) Finished batch should be protected from moisture. Sample for batch uniformity.

Stability of Dry Mixtures PHYSICAL STABILITY Physical stability should evaluate both the dry mixture and reconstituted suspension. Common evaluations on reconstituted suspensions include Sedimentation volume and ease of redispersion. exposure to a cycle of temperature changes (Freeze and Thaw).

Stability of Dry Mixtures CHEMICAL STABILITY Chemical stability should be determined in both the dry mixture and reconstituted suspension. Both should be examined not only at controlled room temperature but also at temperatures of potential exposure such as during shipment or storage of the product. Stability evaluations of reconstituted oral suspensions should be conducted in a container of the same material and size in which the product is marketed. Effectiveness of the preservative is determined by challenge tests. Drug products are often exposed to elevated temperatures for the determination of a shelf-life (i.e., accelerated stability studies).

Guidelines for Stability Testing A screen based on temperature is a common test. Samples of the reconstituted suspension are stored in containers at room temperature, 37, and 45 C. Evaluated monthly for up to 4 months and should include: Chemical analysis for drug and preservative Preservative challenge test at the initiation and conclusion of the study Appearance compared to that of sample stored at 2 to 5 C Viscosity Homogeneity ph Sedimentation volume Ease of redispersion

Freeze-thaw test Conducted by placing the sample in a freezer for 18 hours followed by thawing at room temperature for 4 to 6 hours. Evaluate the appearance and conduct any other appropriate tests at this time. Repeat the Freeze-Thaw cycle for up to 10 times Full-Scale Stability Final formulation should be placed in the container for marketing and should be stored at 2 to 5, RT, 37, and 45 C.

Comparison of Ingredients in Two Commercial Amoxicillin Suspensions for Reconstitution Ingrdient function Product1 Product2 Active Ingredient Sweetener Suspending agent Desiccant Buffer Preservative Colorant Flavor Amoxicillin trihydrate Sucrose Xanthan gum Silica gel Sodium Citrate Sodium benzoate FD&C Red N0.3 Flavors Amoxicillin trihydrate Sucrose, Mannitol Cellulose, Na CMC Sodium Citrate FD&C Red N0.40 Artificial flavors

conclusion The dry syrup preparation is suitable not only for children but also aged persons in view of easier administration. Particularly dry syrup preparation is advantageous because it is easily weighed and packaged and further it is convenient for carrying.

References Herbert A.Lieberman, Martin M.Rieger and Gilbert S.Banker, Pharmaceutical dosage forms: Disperse systems, 2nd edition, volume-2. Howard C.Ansel, Loyd V.Allen, Jr.Nicholas,G.Popovich, Pharmaceutical dosage forms and drug delivery systems,7 th edition. A.P. Pawer and R.S. Gaud,Modern dispensing pharmacy,2 nd edition.

Thank U